Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2010; 16(46): 5881-5888
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5881
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5881
Impact of KRAS mutation and PTEN expression on cetuximab-treated colorectal cancer
Fang-Hua Li, Zhuang-Hua Li, Hui-Yan Luo, Miao-Zhen Qiu, Yu-Hong Li, Rui-Hua Xu, State Key Laboratory of Oncology in Southern China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Fang-Hua Li, Department of Medical Oncology, Shengli Oil Field Central Hospital, Dongying 257034, Shandong Province, China
Lin Shen, Department of GI Oncology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, China
Hui-Zhong Zhang, State Key Laboratory of Oncology in Southern China, Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China
Author contributions: Xu RH and Shen L were involved in the design of the study; Li FH, Li ZH, Luo HY and Qiu MZ performed the laboratory assays; Li FH, Luo HY and Li YH were involved in the writing of the article; Zhang HZ coordinated and provided the collection of all the human materials.
Supported by Program for New Century Excellent Talents in University
Correspondence to: Rui-Hua Xu, MD, PhD, State Key Laboratory of Oncology in Southern China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510060, Guangdong Province, China. xurh@sysucc.org.cn
Telephone: +86-20-87343228 Fax: +86-20-87343228
Received: June 1, 2010
Revised: July 27, 2010
Accepted: August 3, 2010
Published online: December 14, 2010
Revised: July 27, 2010
Accepted: August 3, 2010
Published online: December 14, 2010
Core Tip